Value drivers of development stage biopharma companies.
Daniel Tobias MichaeliHasan Basri YagmurTimur AchmadeevThomas MichaeliPublished in: The European journal of health economics : HEPAC : health economics in prevention and care (2022)
Internal and external drug development consumes many financial and human resources, yet it is important for entrepreneurs, regulators, and payers to understand their precise magnitude and value drivers. This information permits the design of targeted pricing and industrial policies that incentivize the development of novel drugs in areas with high unmet needs.